- Oral presentation
- Open access
- Published:
Detection of Novel Neutralizing Antibody Reactivities Against The Membrane Proximal External Region (MPER) of gp41 in HIV-1 Infected Humans
Retrovirology volume 2, Article number: S102 (2005)
Background
Previously, we employed site-directed mutagenesis to introduce HIV-1 4E10 and 2F5 epitopes into the corresponding region of a functional HIV-2 envelope glycoproteins (AIDS Vaccine 2005, abstract #A210). The resulting "chimeric" viruses were used to screen HIV-1 infected human plasma for 4E10 or 2F5-like neutralizing antibodies (Nabs). Among 177 subjects infected with HIV-1 representing ten different subtypes or circulating recombinant forms, none had significant Nab titers directed toward these epitopes.
Materials and methods
Here, we tested the same HIV-1 positive plasma specimens for neutralizing activity against chimeric HIV-2 viruses in which we substituted the complete 25 amino acid HIV-1 MPER (designated clone C1) or non-overlapping amino-terminal or carboxy-terminal portions of it (designated C3 and C4, respectively) using a single-cycle infectivity assay (Nature 422:307, 2003).
Results
HIV-2 viruses containing the C1, C3 or C4 MPER, and the parental virus HIV-2/7312A, were infectious and equally susceptible to neutralization by T1249, sCD4, the anti-HIV-2 Env mAb 1.7A, and polyclonal anti-HIV-2 antibodies. This result demonstrates that none of the chimeric HIV-2 viruses was "globally sensitive" to neutralization. Surprisingly, 60 out of 165 (36%) of HIV-1 plasmas tested contained MPER specific Nabs. IC50 titers ranged from 0.0005–0.02 (mean 0.006; median 0.004; standard deviation 0.004). Anti-MPER Nab reactivities were mapped to C3 (6 subjects) or C4 (14 subjects) regions of the HIV-1 MPER or to epitopes spanning them (13 subjects). None of the 60 subjects with Nabs to C1, C3, or C4 had antibodies that neutralized HIV-2 viruses containing 2F5 or 4E10 epitopes only.
Conclusion
These results indicate that the MPER of HIV-1 elicits Nab responses in a substantial proportion of infected patients and that the epitopes recognized by these Nabs are distinct from those recognized by 4E10 or 2F5.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution License ( https://creativecommons.org/licenses/by/2.0 ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
About this article
Cite this article
Shaw, G.M. Detection of Novel Neutralizing Antibody Reactivities Against The Membrane Proximal External Region (MPER) of gp41 in HIV-1 Infected Humans. Retrovirology 2 (Suppl 1), S102 (2005). https://doi.org/10.1186/1742-4690-2-S1-S102
Published:
DOI: https://doi.org/10.1186/1742-4690-2-S1-S102